What are the clinical features, diagnosis, and recommended management of fifth disease (erythema infectiosum)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Fifth Disease (Erythema Infectiosum)

Fifth disease is a self-limited viral exanthem caused by parvovirus B19 that requires only supportive care in healthy children and adults, with diagnosis made clinically based on the characteristic "slapped cheek" appearance and lacy reticular rash. 1

Clinical Features

Classic Presentation in Children

The disease evolves through three distinct stages:

Stage 1 (Days 0-2):

  • Bright erythematous rash on both cheeks creating the pathognomonic "slapped cheek" appearance
  • Circumoral pallor (sparing around the mouth)
  • Mild prodromal symptoms may precede: low-grade fever, headache, malaise, myalgia 1

Stage 2 (Days 1-4 after facial rash):

  • Diffuse macular erythema spreads to trunk, extremities, and buttocks
  • More intense on extensor surfaces
  • Palms and soles typically spared
  • Central clearing creates characteristic lacy or reticulated pattern 1

Stage 3 (Weeks 1-3):

  • Evanescence and recrudescence of rash
  • Triggered by sunlight, heat, exercise, emotional stress
  • Rash resolves spontaneously within three weeks 1

Adult Presentation

Adults present differently than children:

  • Only 20% develop facial erythema
  • Rash more commonly on legs (most frequent), then trunk, then arms
  • Reticulated/lacy pattern in 80% of cases
  • Pruritus in approximately 50% 1
  • Arthropathy is the dominant manifestation - symmetric polyarthralgia/arthritis affecting hands, wrists, knees, ankles 2

Key Epidemiologic Features

  • Incubation period: 4-14 days
  • Peak age: 4-10 years old
  • Transmission: respiratory secretions, saliva
  • Contagious during prodrome, not contagious once rash appears 1

Diagnosis

Clinical diagnosis is sufficient in typical cases - no laboratory testing needed for straightforward presentations 1, 3.

When to Consider Laboratory Testing

Order parvovirus B19 IgM and IgG serology when:

  • Pregnant patient with exposure (critical for fetal risk assessment) 4
  • Immunocompromised patient
  • Patient with chronic hemolytic anemia (risk of aplastic crisis)
  • Atypical presentation requiring confirmation 1

Differential Diagnosis to Exclude

The lacy reticular pattern helps distinguish from:

  • Viral exanthems: Roseola (HHV-6), enteroviral infections, EBV - lack the slapped cheek and lacy pattern 5
  • Scarlet fever: Sandpaper texture, strawberry tongue, circumoral pallor different from slapped cheek 6
  • Kawasaki disease: Requires fever ≥5 days plus 4 of 5 criteria (conjunctivitis, oral changes, extremity changes, rash, lymphadenopathy) 6
  • Drug reactions: History of new medication
  • Lyme disease (erythema migrans): Single expanding lesion with central clearing, not diffuse lacy pattern 7

Management

Healthy Children and Adults

Supportive care only:

  • Reassurance about self-limited course
  • Antipyretics for fever (acetaminophen or ibuprofen)
  • Antihistamines for pruritus if present
  • No isolation needed once rash appears (no longer contagious) 1, 3

Adults with Arthropathy

For significant joint symptoms:

  • NSAIDs (naproxen) as first-line
  • Consider short course of corticosteroids for severe cases
  • Conservative physical therapy, joint mobilization may provide adjunctive benefit 2
  • Symptoms typically resolve within weeks to months

High-Risk Populations Requiring Specialist Consultation

Pregnant women with confirmed acute infection:

  • Risk of fetal hydrops fetalis (approximately 10% if infected in first 20 weeks)
  • Serial ultrasounds every 1-2 weeks for 8-12 weeks to monitor for hydrops
  • Refer to maternal-fetal medicine for intrauterine transfusion if hydrops develops 4

Immunocompromised patients:

  • Risk of chronic anemia/pure red cell aplasia
  • May require IVIG therapy
  • Infectious disease consultation recommended 1

Patients with chronic hemolytic anemia (sickle cell, hereditary spherocytosis):

  • Risk of transient aplastic crisis
  • Monitor hemoglobin closely
  • May require transfusion support 1

Critical Pitfalls to Avoid

  1. Do not isolate patients once rash appears - they are no longer contagious, unlike measles or other viral exanthems where isolation continues during rash phase

  2. Do not miss pregnancy status - always ask about pregnancy in women of childbearing age, as fetal complications are the primary serious concern

  3. Do not confuse with Kawasaki disease - Fifth disease lacks the prolonged fever, conjunctivitis, and oral/extremity changes of Kawasaki; missing Kawasaki risks coronary artery aneurysms

  4. Recognize that facial rash is often absent in adults - arthropathy may be the only manifestation, leading to misdiagnosis as rheumatoid arthritis or other inflammatory arthritis

  5. Remember recrudescence is normal - warn patients the rash may come and go for weeks with triggers like sun exposure; this does not indicate treatment failure or reinfection

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.